Iterum Therapeutics Plc (ITRM)

Feb 18, 2025

Iterum Therapeutics plc (NASDAQ:ITRM) Short Interest Down 5.3% in January - Defense World

Feb 18, 2025

Feb 14, 2025

Iterum Therapeutics faces Nasdaq non-compliance issue - MSN

Feb 14, 2025

Feb 11, 2025

A stock that deserves closer examination: Iterum Therapeutics Plc (ITRM) - US Post News

Feb 11, 2025

Feb 10, 2025

Iterum Therapeutics Plc [ITRM] Insider Activity: An Update for Investors - Knox Daily

Feb 10, 2025

Feb 10, 2025

ITRM Posts Updates From FDA Advisory Meeting for UTI Drug, Stock Down - MSN

Feb 10, 2025

Feb 10, 2025

A better buy-in window may exist right now for Iterum Therapeutics Plc (ITRM) - SETE News

Feb 10, 2025

Feb 10, 2025

Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results -February 10, 2025 at 10:41 am EST - Marketscreener.com

Feb 10, 2025

Feb 09, 2025

Iterum outlines ORLYNVAH's market potential with exclusivity through 2034 - MSN

Feb 09, 2025

Feb 08, 2025

Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 08, 2025

Feb 08, 2025

Iterum Therapeutics PLC (ITRM) Q4 2024 Earnings Call Highlights: Navigating Financial ... - Yahoo Finance

Feb 08, 2025

Feb 07, 2025

Iterum Therapeutics Highlights FDA Approval and Financial Progress - TipRanks

Feb 07, 2025

Feb 07, 2025

Earnings call transcript: Iterum Therapeutics reports Q4 2024 results and stock surges - MSN

Feb 07, 2025

Feb 07, 2025

Iterum Therapeutics PLC Files For Mixed Shelf Of Up To $150 Million -February 07, 2025 at 04:42 pm EST - Marketscreener.com

Feb 07, 2025

Feb 07, 2025

Iterum Therapeutics Plc’s Shares Reel: 14.34% Quarterly Revenue Decline Amid 40.59M Market Cap - The InvestChronicle

Feb 07, 2025

Feb 07, 2025

Iterum Therapeutics PLC reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 07, 2025

Feb 07, 2025

Iterum Therapeutics plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com

Feb 07, 2025

Feb 07, 2025

Iterum Therapeutics plc (ITRM) reports earnings - Quartz

Feb 07, 2025

Feb 07, 2025

Iterum Therapeutics plc SEC 10-K Report - TradingView

Feb 07, 2025

Feb 07, 2025

ForexTV | Small Business Resources - ForexTV.com

Feb 07, 2025

Feb 07, 2025

Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times

Feb 07, 2025

Feb 07, 2025

Iterum's Landmark UTI Drug ORLYNVAH Powers Financial Turnaround in Q4 Report - StockTitan

Feb 07, 2025

Feb 07, 2025

Iterum Therapeutics Plc (ITRM) Shares Down Despite Recent Market Volatility - The News Heater

Feb 07, 2025

Feb 06, 2025

Iterum Therapeutics (ITRM) Expected to Announce Quarterly Earnings on Friday - Defense World

Feb 06, 2025

Feb 05, 2025

Is Iterum Therapeutics Plc (ITRM) a good investment opportunity? - US Post News

Feb 05, 2025

Feb 04, 2025

Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025 - Marketscreener.com

Feb 04, 2025

Jan 31, 2025

Iterum Therapeutics (NASDAQ:ITRM) Stock Quotes, Forecast and News Summary - Benzinga

Jan 31, 2025

Jan 31, 2025

Iterum Pharmaceuticals Earnings: Q4 Results and Pipeline Updates Coming February 7 - StockTitan

Jan 31, 2025

Jan 01, 2025

Short Interest in Iterum Therapeutics plc (NASDAQ:ITRM) Drops By 10.3% - Defense World

Jan 01, 2025

Dec 07, 2024

Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH™ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections - The Eastern Progress Online

Dec 07, 2024

Dec 02, 2024

Iterum Therapeutics stock hits 52-week high at $2.35 By Investing.com - Investing.com UK

Dec 02, 2024

Nov 23, 2024

Metrics That Matter About Iterum Therapeutics Plc (NASDAQ: ITRM) - Stocks Register

Nov 23, 2024

Nov 21, 2024

Iterum Therapeutics Regains Full Nasdaq Compliance - The Manila Times

Nov 21, 2024

Nov 19, 2024

Iterum Therapeutics to Host Morning Conference Call on U.S. FDA - GuruFocus.com

Nov 19, 2024

Nov 15, 2024

Iterum Therapeutics plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 15, 2024

Nov 15, 2024

Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Nov 15, 2024

Iterum Therapeutics plc (ITRM) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Iterum Therapeutics PLC - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Iterum Therapeutics PLC (ITRM) Q3 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges - GuruFocus.com

Nov 15, 2024

Nov 15, 2024

Iterum Therapeutics PLC (ITRM) Q3 2024 Earnings Call Highlights: Strategic Moves Amid Financial ... By GuruFocus - Investing.com Canada

Nov 15, 2024

Nov 15, 2024

Iterum Therapeutics PLC (ITRM) Q3 2024 Earnings Call Highlights: Strategic Moves Amid Financial ... - Yahoo Finance

Nov 15, 2024

Nov 14, 2024

Iterum Therapeutics’ Strategic Advances with ORLYNVAH Approval - TipRanks

Nov 14, 2024

Nov 14, 2024

Earnings Flash (ITRM) ITERUM THERAPEUTICS Reports Q3 Loss $-0.24 - Marketscreener.com

Nov 14, 2024

Nov 14, 2024

Iterum Therapeutics Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 14, 2024

Nov 14, 2024

Iterum Therapeutics sees cash runway into 2025 - TipRanks

Nov 14, 2024

Nov 14, 2024

Iterum's ORLYNVAH Gets FDA Nod; Q3 Shows $14.5M Cash Position Amid Wider Losses | ITRM Stock News - StockTitan

Nov 14, 2024

Nov 13, 2024

Iterum Therapeutics (ITRM) Scheduled to Post Earnings on Thursday - Defense World

Nov 13, 2024

Nov 13, 2024

A Look at Iterum Therapeutics's Upcoming Earnings Report - Benzinga

Nov 13, 2024

Nov 11, 2024

Iterum Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024 - The Manila Times

Nov 11, 2024

Nov 02, 2024

Iterum Therapeutics defers $20 million FDA milestone payment - Investing.com India

Nov 02, 2024

Nov 01, 2024

Iterum Therapeutics defers $20 million FDA milestone payment By Investing.com - Investing.com Australia

Nov 01, 2024

Nov 01, 2024

Iterum Therapeutics : Financial Obligation Form 8 K - Marketscreener.com

Nov 01, 2024

Nov 01, 2024

500: Something went wrong - Investing.com UK

Nov 01, 2024